HAS Authority Over Cancer Program Become Hot Issues; Fredrickson Opposes Exemption For NCI
In Brief: Cancer Claims Morris Kupchan, Who Found Promising New Antitumor Drugs In Plants
L-PAM Benefit To Post-Menopausal Patients Challenged
NCI Relates FDA Instructions On Latest IND Delays
Two Workshops To Look For New Research Areas
Proposed Regulations for Center Grants In Federal Register
Obey Attacks NCI In Campaign Speech
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - Alec Kimmelman announced as next CEO and Dean of NYU Langone Health